Table 6.
Data | Sample (n) | PF | RF | CF | EF | SF | QL | FS | PS | NVS |
---|---|---|---|---|---|---|---|---|---|---|
Our study | 120 (CRC) | 0.79 | 0.82 | 0.80 | 0.80 | 0.83 | 0,82 | 0,78 | 0.79 | 0.83 |
Moroccan (Nejjari) | 125 (HC) | 0.84 | 0.94 | 0.34 | 0.89 | 0.80 | 0.87 | 0.83 | 0.78 | 0.74 |
Lebanese | 200 (HC) | 0.89 | 0.80 | 0.60 | 0.79 | 0.65 | 0.89 | 0.81 | 0.75 | 0.43 |
United Arab Emirates | 87 (BC) | 0.76 | 0.84 | 0.67 | 0.87 | 0.79 | 0.86 | 0.84 | 0.50 | 0.86 |
Malysian chinese | 96 (CRC) | 0.74 | 0.92 | 0.26( | 0.79 | 0.71 | 0.91 | 0.79 | 0.77 | 0.82 |
American | 489 (NCP) | 0.77 | 0.88 | 0.58 | 0.84 | 0.80 | 0.84 | 0.81 | 0.83 | 0.50 |
Turkish | 194 (LC) | 0.70 | 0.89 | 0.71 | 0.84 | 0.76 | 0.94 | 0.94 | 0.87 | 0.76 |
German | 1864 (HC) | 0.57 | 0.36 | 0.85 | 0.72 | 0.78 | 0.90 | 0.86 | 0.89 | 0.75 |
Ethiopian Amharic | 153 (GC) | 0.83 | – | 0.29 | 0.93 | 0.82 | 0.92 | 0.89 | 0.73 | 0.75 |
Brazilian portugese | 986 (LC) | 0.80 | 0.79 | 0.57 | 0.84 | 0.69 | 0.78 | 0.78 | 0.81 | 0.68 |
Iranian | 132 (BC) | 0.76 | 0.77 | 0.77 | 0.77 | 0.73 | 0.82 | 0.65 | 0.66 | 0.69 |
indonesian | 128 (HC) | 0.82 | 0.79 | 0.82 | 0.78 | 0.83 | 0.80 | 0.72 | 0.85 | 0.70 |
korean | 170 (NC) | 0.87 | 0.87 | 0.60 | 0.86 | 0.82 | 0.84 | 0.78 | 0.84 | 0.85 |
Spanish mexican | 150 (GRC) | 0.79 | 0.8 | 0.32 | 0.85 | 0.8 | 0.9 | 0.78 | 0.55 | 0.8 |
Taiwan chinese | 99 (LC) | 0.85 | 0.92 | 0.58 | 0.81 | 0.82 | 0.86 | 0.80 | 0.81 | 0.74 |
Thailand | (NC) | 0.75 | 0.76 | 0.50 | 0.86 | 0.63 | 0.90 | 0.73 | 0.80 | 0.82 |
CRC (colorectal cancer), HC (heterogenous cancers), BC (breast cancer), NCP (non cancerous population), LC (lung cancer), GC (gynecological cancer),GRC (gastric cancer)